Table 2.
Clinical testing of pediatric patients with SARS-CoV-2 Omicron BA.2.38 infection.
| Index | Classification | n | M(Q) | Mann-Whitney U test | p-value |
|---|---|---|---|---|---|
| ALT first timea | Asymptomatic | 26 | 14.0 (11, 23) | 332 | 0.052 |
| Symptomatic | 36 | 19.0 (14, 28) | |||
| AST first time | Asymptomatic | 26 | 25.0 (21, 34) | 301 | 0.017 |
| Symptomatic | 36 | 34.0 (26, 43) | |||
| CRP first time | Asymptomatic | 23 | 0.0 (0, 1) | 184 | 0.004 |
| Symptomatic | 30 | 3.0 (1, 9) | |||
| SARS-CoV-2 N-gene first time | Asymptomatic | 10 | 27.0 (22.2, 31.5) | 135 | 0.32 |
| Symptomatic | 22 | 25.0 (20.2, 28.0) | |||
| SARS-CoV-2 ORF1ab first time | Asymptomatic | 10 | 26.0 (22.0, 30.5) | 134 | 0.33 |
| Symptomatic | 22 | 24.0 (19.2, 27.8) | |||
| D2 dimer first time | Asymptomatic | 25 | 0.3 (0.22, 0.39) | 322 | 0.12 |
| Symptomatic | 34 | 0.35 (0.28, 0.52) | |||
| WBC first time | Asymptomatic | 26 | 6.5 (5.40, 7.80) | 454 | >0.99 |
| Symptomatic | 35 | 7.5 (4.80, 9.70) | |||
| γ-Glutamyl transferase first time | Asymptomatic | 24 | 14.0 (13, 16) | 240 | 0.32 |
| Symptomatic | 24 | 15.0 (12, 21) | |||
| Neutrophils first time | Asymptomatic | 26 | 2.95 (2.20, 3.98) | 438 | 0.81 |
| Symptomatic | 35 | 2.9 (2.30, 3.95) | |||
| Lactate dehydrogenase first time | Asymptomatic | 26 | 229.0 (204, 308) | 380 | 0.27 |
| Symptomatic | 35 | 263.0 (217, 319) | |||
| Urea nitrogen first time | Asymptomatic | 26 | 4.9 (3.90, 5.45) | 487 | 0.65 |
| Symptomatic | 35 | 4.4 (3.55, 5.50) | |||
| Leukomonocyte first time | Asymptomatic | 26 | 2.5 (2.00, 4.35) | 489 | 0.62 |
| Symptomatic | 35 | 2.5 (1.35, 5.20) | |||
| Interleukin 6 first time | Asymptomatic | 22 | 4.1 (2.23, 4.66) | 207 | 0.034 |
| Symptomatic | 29 | 5.42 (3.01, 7.87) | |||
| Alkaline phosphatase first time | Asymptomatic | 24 | 224.0 (197, 267) | 272 | 0.75 |
| Symptomatic | 24 | 231.0 (198, 267) | |||
| Fibrinogen first time | Asymptomatic | 25 | 2.09 (1.88, 2.31) | 302 | 0.061 |
| Symptomatic | 34 | 2.28 (1.99, 2.75) | |||
| Creatinine first time | Asymptomatic | 26 | 38.0 (32, 42) | 478 | 0.74 |
| Symptomatic | 35 | 36.0 (29, 49) | |||
| Creatine kinase isoenzyme MB first time | Asymptomatic | 26 | 18.0 (14, 22) | 384 | 0.3 |
| Symptomatic | 35 | 20.0 (16, 30) | |||
| Creatine kinase first time | Asymptomatic | 26 | 74.0 (57, 108) | 428 | 0.7 |
| Symptomatic | 35 | 89.0 (55, 111) | |||
| Platelet first time | Asymptomatic | 26 | 270.0 (230, 335) | 492 | 0.6 |
| Symptomatic | 35 | 260.0 (197, 312) | |||
| Serum amyloid A measure first time | Asymptomatic | 19 | 18.0 (1, 27) | 233 | 0.22 |
| Symptomatic | 31 | 24.0 (16, 29) | |||
| Hemoglobin first time | Asymptomatic | 26 | 127.0 (122, 134) | 489 | 0.62 |
| Symptomatic | 35 | 127.0 (120, 132) | |||
| Procalcitonin first time | Asymptomatic | 22 | 0.08 (0.07, 0.10) | 221 | 0.064 |
| Symptomatic | 29 | 0.1 (0.08, 0.18) |
a
First laboratory test results after admission.